Skip to main content
logo
HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
1.450
-0.180 (-11.04%)
At close: Jun 8, 2026, 4:00 PM EDT
1.350
-0.100 (-6.90%)
After-hours: Jun 8, 2026, 7:59 PM EDT

HCW Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6.590.052.572.846.72-
Revenue Growth (YoY)
356.16%-97.89%-9.68%-57.73%--
Cost of Revenue
0.050.041.612.284.14-
Gross Profit
6.540.010.960.562.59-
Selling, General & Admin
7.66.2322.7313.358.335.19
Research & Development
5.225.446.397.689.348.17
Other Operating Expenses
1.71.51.35.25--
Total Operating Expenses
14.5213.1730.4226.2817.6713.37
Operating Income
-7.98-13.16-29.46-25.72-15.08-13.37
Interest Expense
-0.68-0.85-0.65-0.28-0.13-
Other Non-Operating Income (Expense)
6.76.050.091.010.30.51
Total Non-Operating Income (Expense)
6.025.2-0.570.720.180.51
Pretax Income
3.8-7.96-30.02-24.99-14.9-12.86
Provision for Income Taxes
0.33-----
Net Income
-2.29-7.96-30.02-24.99-14.9-12.86
Net Income Attributable to Preferred Dividends
-15.83-14.34----
Net Income to Common
-18.12-22.3-30.02-24.99-14.9-12.86
Shares Outstanding (Basic)
321110
Shares Outstanding (Diluted)
321110
Shares Change (YoY)
216.07%116.30%7.97%0.30%90.84%296.07%
EPS (Basic)
-9.46-10.63-30.96-28.00-16.80-27.60
EPS (Diluted)
-9.46-10.63-30.96-28.00-16.80-27.60
Free Cash Flow
-11.45-13.39-14.49-28.72-20.66-11.02
Free Cash Flow Per Share
-3.57-6.38-14.94-31.97-23.07-23.49
Gross Margin
99.24%20.00%37.38%19.72%38.48%-
Operating Margin
-121.09%-24270.70%-1147.60%-904.96%-224.32%-
Profit Margin
-34.74%-14677.10%-1169.70%-879.52%-221.67%-
FCF Margin
-173.74%-24693.20%-564.48%-1010.51%-307.36%-
EBITDA
-7.22-12.12-28.27-24.58-14.36-12.82
EBITDA Margin
-109.49%-22349.80%-1101.46%-865.02%-213.64%-
EBIT
-7.98-13.16-29.46-25.72-15.08-13.37
EBIT Margin
-121.09%-24270.70%-1147.60%-904.96%-224.32%-
Effective Tax Rate
8.68%0.00%0.00%0.00%0.00%0.00%
SEC Filings: 10-K · 10-Q